610,329,800 Ordinary Shares of SciClone Pharmaceuticals (Holdings) Limited are subject to a Lock-Up Agreement Ending on 3-SEP-2021. These Ordinary Shares will be under lockup for 186 days starting from 1-MAR-2021 to 3-SEP-2021.
Each of Avengers Limited, Ascendent Silver (Cayman) Limited, Ocean Falcon Limited, Boying Investments Limited, Convergence International Holdings Ltd. and Corto Co., Ltd. (the Undersigned Shareholders) has agreed to enter into a lock-up undertaking deed in favor of the Joint Sponsors and the Joint Representatives. Pursuant to the Lock-up Undertaking Deeds, each of the Undersigned Shareholders agrees that, it will not, from the date of the respective Lock-up Undertaking Deed and ending on, and including, the date that is six months after the Listing Date (the Six-Month Period), dispose of any Relevant Shares or any interest in any company or entity holding or controlling (directly or indirectly) any Relevant Shares or, permit or cause a change in control of any company or entity holding or controlling (directly or indirectly) any Relevant Shares.
GL Capital Group, single largest Shareholder, has undertaken to the Hong Kong Stock Exchange that, it shall not, unless in compliance with the requirements of the Listing Rules, in the period commencing on the date by reference to which disclosure of its shareholding is made in this prospectus and ending on the date which is six months from the Listing Date (the First SixMonth Period), dispose of, nor enter into any agreement to dispose of or otherwise create any options, rights, interests or encumbrances in respect of, any of the Shares in respect of which it is shown by this prospectus to be the beneficial owner.
The shares held by the cornerstone investors to be held under lock up until September 03, 2021.